Imagabalin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Imagabalin
Imagabalin.svg
Systematic (IUPAC) name
(3S,5R)-3-amino-5-methyloctanoic acid
Clinical data
Legal status ?
Identifiers
CAS number 610300-07-7
610300-00-0 (hydrochloride)
ATC code None
PubChem CID 10236037
ChemSpider 8411525
Synonyms PD-0332334; PD-332,334
Chemical data
Formula C9H19NO2 
Mol. mass 173.253 g/mol

Imagabalin (INN, USAN; PD-332,334) is a drug which acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel,[1] with some selectivity for the α2δ1 subunit over α2δ2.[2] Under development by Pfizer as a pharmaceutical medication, it has demonstrated preclinical efficacy of anxiolytic, analgesic, hypnotic, and anticonvulsant-like activity and is currently in phase III clinical trials for the treatment of generalized anxiety disorder.[2][3]

See also[edit]

References[edit]